Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acelrx Pharmaceutica (NQ: ACRX )

1.060 USD +0.040 (+3.92%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 516,152
Open 1.010
Bid (Size) 1.050 (10)
Ask (Size) 1.060 (3)
Prev. Close 1.020
Today's Range 1.010 - 1.060
52wk Range 0.7500 - 2.940
Shares Outstanding 119,179,806
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AcelRx Pharmaceuticals to Participate in Two September Investor Conferences
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised... 
From PR Newswire
Study Results Announced During Award-Winning Presentation on the Effect of Sufentanil Sublingual Tablet on Outpatient Plastic Surgery at the Annual Miami Cosmetic Surgery Event
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised... 
From PR Newswire

Performance

YTD
-15.20%
-15.20%
1 Month
-2.75%
-2.75%
3 Month
-25.35%
-25.35%
6 Month
-36.53%
-36.53%
1 Year
-28.86%
-28.86%

More News

Read More
Presentation on the Effect of the Administration of Sufentanil Sublingual Tablet on Reducing Post-Operative Recovery Time and Opioid Use in Plastic Surgery at the Annual Miami Cosmetic Surgery Event
From PR Newswire
5 Penny Stocks To Buy According To Top Wall Street Analysts In 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
AcelRx Pharmaceuticals Reports Second Quarter 2021 Financial Results
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX
From PR Newswire
AcelRx to Host Second Quarter 2021 Financial Results Call and Webcast on August 16, 2021
From PR Newswire
ACRX FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Monday Deadline in Securities C
From GlobeNewswire News Releases
AcelRx Pharmaceuticals, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Wednesday's Intraday Session
Tags NRXP BZI/TFM Intraday Update
From Benzinga
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.